Current treatment options for systemic lupus erythematosus (SLE) consists of glucocorticoids, antimalarials, immunosuppressives, and a few biologics, approved or of 'off-label'. Through judicious ...

Systemic Lupus Erythematosus ('lupus') is an autoimmune disease with symptoms ranging from joint pains to potentially life-threatening heart, lung, brain, and/or kidney damage.

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop it in its tracks.

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory systemic lupus erythematosus (SLE) get symptoms under control ...

BARCELONA, Spain — Monitoring blood hydroxychloroquine levels could help to ensure that patients with systemic lupus erythematosus (SLE) are being treated with the drug optimally, according to ...

Most lupus patients are women and many are Black women. They can suffer rashes, fatigue and kidney problems but may not know their big risk for heart disease.

Systemic lupus erythematosus, a.k.a. lupus, is a chronic autoimmune condition that causes the immune system to attack healthy tissues and organs. It can affect the joints, skin, kidneys, blood ...

Belimumab increases the complete renal response rate among patients with pure or mixed proliferative class 3 or 4 lupus nephritis (LN) treated with mycophenolate mofetil (MMF).

Leukemia and lupus are both conditions that affect the immune system. Although they are different, they share certain symptoms. A person with lupus may have increased risk of developing leukemia.